Exploring the potential of low doses carbon monoxide as therapy in pregnancy complications

Medical Gas Research

Volumn 2, Issue 1, 2012, Pages

  El Mousleh, Tarek ^a,b   Casalis, Pablo A ^a   Wollenberg, Ivonne ^a   Zenclussen, Maria L ^a   Volk, Hans D ^b   Langwisch, Stefanie ^a   Jensen, Federico ^a   Zenclussen, Ana C ^a,b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; HEME OXYGENASE 1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; FETUS DEATH; FETUS WEIGHT; IN VIVO STUDY; INTRAUTERINE GROWTH RETARDATION; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PLACENTA WEIGHT; PREGNANCY OUTCOME; PRIORITY JOURNAL;

EID: 84894430545     PISSN: None     EISSN: 20459912     Source Type: Journal    
DOI: 10.1186/2045-9912-2-4     Document Type: Article

References (53)

1. Causes of early embryonic loss in human pregnancy. Edwards RG, Hum Reprod 1986 1 185 98 3305553 (Pubitemid 16081188)
2. Embryonic death in early pregnancy: a new look at the first trimester. Goldstein SR, Obstet Gynecol 1994 84 294 7 8041550 (Pubitemid 24234846)
3. Implantation and the placenta: key pieces of the development puzzle. Cross JC, Werb Z, Fisher SJ, Science 1994 266 1508 18 10.1126/science.7985020 7985020
4. Utero-placental vascular development and placental function. Reynolds LP, Redmer DA, J Anim Sci 1995 73 1839 1851 7545661
5. Comparative developmental anatomy of the murine and human definitive placentae. Georgiades P, Ferguson-Smith AC, Burton GJ, Placenta 2002 23 1 3 19 10.1053/plac.2001.0738 11869088
6. Angiogenesis and vasculogenesis in pregnancy. Zygmunt M, Herr F, Münstedt K, Lang U, Liang OD, Eur J Obstet Gynecol Reprod Biol 2003 1 10 8
7. Trophoblast functions, angiogenesis and remodeling of the maternal vasculature in the placenta. Cross JC, Hemberger M, Lu Y, Nozaki T, Whiteley K, Masutani M, Adamson SL, Mol Cell Endocrinol 2002 187 207 12 10.1016/S0303- 7207(01)00703-1 11988329 (Pubitemid 34436950)
8. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A, Nature 1996 380 435 9 10.1038/380435a0 8602241 (Pubitemid 26102719)
9. How to study placental vascular development? Herr F, Baal N, Widmer-Teske R, McKinnon T, Zygmunt M, Theriogenology 2010 73 817 27 10.1016/j. theriogenology.2009.11.003 20036417
10. Placental phenotypes of intrauterine growth. Sibley CP, Turner MA, Cetin I, Ayuk P, Boyd CA, D'Souza SW, Glazier JD, Greenwood SL, Jansson T, Powell T, Pediatr Res 2005 58 827 32 10.1203/01.PDR.0000181381.82856.23 16183820 (Pubitemid 41511049)
11. Placental development in normal and compromised pregnancies - a review. Regnault TR, Galan HL, Parker TA, Anthony RV, Placenta 2002 23 119 29 11978069
12. Haem oxygenase-1 dictates intrauterine fetal survival in mice via carbon monoxide. Zenclussen ML, Casalis PA, El-Mousleh T, Rebelo S, Langwisch S, Linzke N, Volk HD, Fest S, Soares MP, Zenclussen AC, J Pathol 2011 225 293 304 10.1002/path.2946 21744344
13. Carbon Monoxide Has Anti-Inflammatory Effects Involving the Mitogen-Activated Protein Kinase Pathway. Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, Davis RJ, Flavell RA, Choi AM, Nat Med 2000 6 422 428 10.1038/74680 10742149 (Pubitemid 30208159)
14. Carbon Monoxide Generated by Heme Oxygenase 1 Suppresses Endothelial Cell Apoptosis. Brouard S, Otterbein LE, Anrather J, Tobiasch E, Bach FH, Choi AM, Soares MP, J Exp Med 2000 192 1015 1026 10.1084/jem.192.7.1015 11015442
15. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Lee TS, Chau LY, Nat Med 2002 8 240 246 10.1038/nm0302-240 11875494 (Pubitemid 34250101)
16. Hemeoxygenase expression in human placenta and placental bed implies a role in regulation of trophoblast invasion and placental function. Lyall F, Barber A, Myatt L, Bulmer JN, Robson SC, FASEB J 2000 14 208 19 10627295 (Pubitemid 30051538)
17. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE, J Exp Med 2006 203 2165 75 correct? 10.1084/jem.20061022 16923853 (Pubitemid 44352237)
18. Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Zenclussen AC, Gerlof K, Zenclussen ML, Sollwedel A, Bertoja AZ, Ritter T, Kotsch K, Leber J, Volk HD, Am J Pathol 2005 166 811 22 10.1016/S0002-9440(10)62302-4 15743793 (Pubitemid 40315638)
19. Heme Oxygenases in Pregnancy II: HO-2 Is Downregulated in Human Pathologic Pregnancies. Zenclussen AC, Lim E, Knoeller S, Knackstedt M, Hertwig K, Hagen E, Klapp BF, Arck PC, Am J Reprod Immunol 2003 50 66 76 10.1034/j.1600-0897.2003.00047.x 14506930 (Pubitemid 36805766)
20. Heme oxygenase as a therapeutic target in immunological pregnancy complications. Zenclussen AC, Sollwedel A, Bertoja AZ, Gerlof K, Zenclussen ML, Woiciechowsky C, Volk HD, Int Immunopharmacol 2005 5 41 51 10.1016/j.intimp. 2004.09.011 15589458 (Pubitemid 39626682)
21. Protection from Abortion by Heme Oxygenase-1 up-Regulation Is Associated with Increased Levels of Bag-1 and Neuropilin-1 at the Fetal-Maternal Interface. Sollwedel A, Bertoja AZ, Zenclussen ML, Gerlof K, Lisewski U, Wafula P, Sawitzki B, Woiciechowsky C, Volk HD, Zenclussen AC, J Immunol 2005 175 4875 85 16210589 (Pubitemid 41456369)
22. FOXP3+ regulatory T cells and T helper 1, T helper 2, and T helper 17 cells in human early pregnancy decidua. Mjösberg J, Berg G, Jenmalm MC, Ernerudh J, Biol Reprod 2010 82 698 705 10.1095/biolreprod.109.081208 20018909
23. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Piccinni MP, Beloni L, Livi C, Maggi E, Scarselli G, Romagnani S, Nat Med 1998 4 1020 4 10.1038/2006 9734394 (Pubitemid 28417333)
24. Protective effect of vascular endothelial growth factor/vascular permeability factor 165 and 121 on glomerular endothelial cell injury in the rat. Miyamoto K, Kitamoto Y, Tokunaga H, Takeya M, Ezaki T, Imamura T, Tomita K, Lab Invest 2004 84 1126 36 10.1038/labinvest.3700134 15195119 (Pubitemid 39128258)
25. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Kelly BD, Hackett SF, Hirota K, Oshima Y, Cai Z, Berg-Dixon S, Rowan A, Yan Z, Campochiaro PA, Semenza GL, Circ Res 2003 93 1074 1081 10.1161/01.RES.0000102937.50486.1B 14576200 (Pubitemid 37485038)
26. Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning. Chin BY, Jiang G, Wegiel B, Wang HJ, Macdonald T, Zhang XC, Gallo D, Cszimadia E, Bach FH, Lee PJ, Otterbein LE, Proc Natl Acad Sci USA 2007 104 5109 14 10.1073/pnas.0609611104 17360382 (Pubitemid 47186184)
27. Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism. Deshane J, Chen S, Caballero S, Grochot-Przeczek A, Was H, Li Calzi S, Lach R, Hock TD, Chen B, Hill-Kapturczak N, Siegal GP, Dulak J, Jozkowicz A, Grant MB, Agarwal A, J Exp Med 2007 204 605 18 10.1084/jem.20061609 17339405 (Pubitemid 46457083)
28. Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-accelerating factor: a role for increased bilirubin and ferritin. Kinderlerer AR, Pombo Gregoire I, Hamdulay SS, Ali F, Steinberg R, Silva G, Ali N, Wang B, Haskard DO, Soares MP, Mason JC, Blood 2009 113 1598 1607 19036700
29. Relationship between arterial and venous Doppler and perinatal outcome in fetal growth restriction. Baschat AA, Gembruch U, Reiss I, Gortner L, Weiner CP, Harman CR, Ultrasound Obstet Gynecol 2000 16 407 13 10.1046/j.1469-0705. 2000.00284.x 11169323 (Pubitemid 32158116)
30. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction The Vermont Oxford Network. Bernstein IM, Horbar JD, Badger GJ, Ohlsson A, Golan A, Am J Obstet Gynecol 2000 182 198 206 10.1016/S0002-9378(00)70513-8 10649179 (Pubitemid 30074392)
31. Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus. Murphy VE, Smith R, Giles WB, Clifton VL, Endocr Rev 2006 27 141 69 10.1210/er.2005-0011 16434511
32. Paediatric consequences of fetal growth restriction. Yanney M, Marlow N, Semin Fetal Neonatal Med 2004 9 411 8 10.1016/j.siny.2004.03.005 15691777
33. Developmental changes of gene expression in heme metabolic enzymes in rat placenta. Ihara N, Akagi R, Ejiri K, Kudo T, Furuyama K, Fujita H, FEBS Lett 1998 439 163 167 10.1016/S0014-5793(98)01324-6 9849899 (Pubitemid 28537885)
34. Heme Oxygenase Expression in Human Placenta and Placental Bed: Reduced Expression of Placenta Endothelial HO-2 in Pre-Eclampsia and Fetal Growth Restriction. Barber A, Robson SC, Myatt L, Bulmer J, Lyall F, FASEB J 2001 15 1158 1168 10.1096/fj.00-0376com 11344084 (Pubitemid 32436301)
35. Effect of heme oxygenase-1 deficiency on placental development. Zhao H, Wong RJ, Kalish FS, Nayak NR, Stevenson DK, Placenta 2009 30 861 8 10.1016/j.placenta.2009.07.012 19699520
36. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Cudmore M, Ahmad S, Al-Ani B, Fujisawa T, Coxall H, Chudasama K, Devey LR, Wigmore SJ, Abbas A, Hewett PW, Ahmed A, Circulation 2007 115 1789 97 10.1161/CIRCULATIONAHA.106.660134 17389265 (Pubitemid 46648616)
37. Induction of placental heme oxygenase-1 is protective against TNFalpha-induced cytotoxicity and promotes vessel relaxation. Ahmed A, Rahman M, Zhang X, Acevedo CH, Nijjar S, Rushton I, Bussolati B, St John J, Mol Med 2000 6 391 409 10952020
38. Evidence for oxidative stress in the developing cerebellum of the rat after chronic mild carbon monoxide exposure (0.0025% in air). Lopez IA, Acuna D, Beltran-Parrazal L, Lopez IE, Amarnani A, Cortes M, Edmond J, BMC Neurosci 2009 10 53 10.1186/1471-2202-10-53 19580685
39. Over-expression of heme oxygenase-1 by adenoviral gene transfer improves pregnancy outcome in a murine model of abortion. Zenclussen ML, Anegon I, Bertoja AZ, Chauveau C, Vogt K, Gerlof K, Sollwedel A, Volk HD, Ritter T, Zenclussen AC, J Reprod Immunol 2006 69 35 52 10.1016/j.jri.2005.10.001 16386310 (Pubitemid 43144470)
40. Carbon monoxide inhibits hypoxia/reoxygenation-induced apoptosis and secondary necrosis in syncytiotrophoblast. Bainbridge SA, Belkacemi L, Dickinson M, Graham CH, Smith GN, Am J Pathol 2006 169 774 83 10.2353/ajpath.2006.060184 16936254 (Pubitemid 44411945)
41. Heme oxygenase-1/carbon monoxide induces vascular endothelial growth factor expression via p38 kinase-dependent activation of Sp1. Lin HH, Lai SC, Chau LY, J Biol Chem 2011 286 3829 38 10.1074/jbc.M110.168831 21115498
42. Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Dulak J, Deshane J, Jozkowicz A, Agarwal A, Circulation 2008 117 231 41 10.1161/CIRCULATIONAHA.107.698316 18195184
43. Regulation of maternal and fetal hemodynamics by heme oxygenase in mice. Zhao H, Wong RJ, Doyle TC, Nayak N, Vreman HJ, Contag CH, Stevenson DK, Biol Reprod 2008 78 744 51 10.1095/biolreprod.107.064899 18094356 (Pubitemid 351469350)
44. Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Wu L, Wang R, Pharmacol Ren 2005 57 585 630 10.1124/pr.57.4.3 (Pubitemid 43036442)
45. Carbon monoxide signaling in promoting angiogenesis in human microvessel endothelial cells. Li Volti G, Sacerdoti D, Sangras B, Vanella A, Mezentsev A, Scapagnini G, Falck JR, Abraham NG, Antioxid Redox Signal 2005 7 704 10 10.1089/ars.2005.7.704 15890016 (Pubitemid 40563210)
46. Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Dulak J, Jázkowicz A, Foresti R, Kasza A, Frick M, Huk I, Green CJ, Pachinger O, Weidinger F, Motterlini R, Antioxid Redox Signal 2002 4 229 40 10.1089/152308602753666280 12006174 (Pubitemid 34517174)
47. Placenta growth factor: potential role in pregnancy. Torry DS, Ahn H, Barnes EL, Torry RJ, Am J Reprod Immunol 1999 41 79 85 10.1111/j.1600-0897.1999. tb00078.x 10097790 (Pubitemid 29108234)
48. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Wallner W, Sengenberger R, Strick R, Strissel PL, Meurer B, Beckmann MW, Schlembach D, Clin Sci (Lond) 2007 112 51 7 10.1042/CS20060161 (Pubitemid 46120085)
49. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE, J Exp Med 2006 203 2165 2175 10.1084/jem.20061022 16923853 (Pubitemid 44352237)
50. Maternal hypoxia activates endovascular trophoblast cell invasion. Rosario GX, Konno T, Soares MJ, Dev Biol 2008 314 362 75 10.1016/j.ydbio.2007. 12.007 18199431
51. The contribution of placental oxidative stress to early pregnancy failure. Hempstock J, Jauniaux E, Greenwold N, Burton GJ, Hum Pathol 2003 34 1265 75 10.1016/j.humpath.2003.08.006 14691912 (Pubitemid 38018140)
52. Beyond oxygen: complex regulation and activity of hypoxia inducible factors in pregnancy. Pringle KG, Kind KL, Sferruzzi-Perri AN, Thompson JG, Roberts CT, Hum Reprod Update 2010 16 4 415 31 Jul-Aug 10.1093/humupd/dmp046 19926662
53. HIF-1 activation attenuates postischemic myocardial injury: role for heme oxygenase-1 in modulating microvascular chemokine generation. Ockaili R, Natarajan R, Salloum F, Fisher BJ, Jones D, Fowler AA, Kukreja RC, Am J Physiol Heart Circ Physiol 2005 289 542 8 10.1152/ajpheart.00089.2005 15805230 (Pubitemid 41129367)